Julius Strauss
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 47
- Cancer Immunotherapy and Biomarkers 38
- Colorectal Cancer Treatments and Studies 7
-
- Prostate Cancer Treatment and Research 16
- Co-authors
- James L. Gulley (65 shared papers)Jeffrey Schlom (47 shared papers)Renee N. Donahue (31 shared papers)Ravi A. Madan (41 shared papers)Jennifer L. Marté (30 shared papers)Christopher R. Heery (14 shared papers)Claudia Palena (8 shared papers)Caroline Jochéms (15 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)Journal for ImmunoTherapy of Cancer (8 papers)Annals of Oncology (7 papers)The Oncologist (7 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Julius Strauss
76 papers receiving 1.7k citations
Julius Strauss's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 1.0k
- Immunology 631
- Biotechnology 75
- Cancer Research 112
- Pulmonary and Respiratory Medicine 221
Countries citing papers authored by Julius Strauss
This map shows the geographic impact of Julius Strauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julius Strauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julius Strauss more than expected).
Fields of papers citing papers by Julius Strauss
This network shows the impact of papers produced by Julius Strauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julius Strauss. The network helps show where Julius Strauss may publish in the future.
Co-authors
The 25 scholars most cited alongside Julius Strauss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors Hit paper breakdown → | 2018 | 333 |
| 2 | 2020 | 210 | |
| 3 | 2019 | 200 | |
| 4 | 2018 | 122 | |
| 5 | 2017 | 78 | |
| 6 | 2019 | 48 | |
| 7 | 2021 | 47 | |
| 8 | 2019 | 46 | |
| 9 | 2021 | 43 | |
| 10 | 2019 | 42 | |
| 11 | Using Epigenetic Therapy to Overcome Chemotherapy Resistance. | 2016 | 32 |
| 12 | 2022 | 30 | |
| 13 | 2022 | 24 | |
| 14 | 2016 | 24 | |
| 15 | 2020 | 20 | |
| 16 | 2019 | 19 | |
| 17 | 2018 | 19 | |
| 18 | 2023 | 18 | |
| 19 | 2021 | 17 | |
| 20 | 2022 | 16 |
About Julius Strauss
Julius Strauss is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Biotechnology, having authored 82 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (38 papers), Prostate Cancer Treatment and Research (16 papers), Immunotherapy and Immune Responses (15 papers), Cancer Research and Treatments (10 papers), Colorectal Cancer Treatments and Studies (7 papers), Colorectal and Anal Carcinomas (5 papers), Virus-based gene therapy research (5 papers) and TGF-β signaling in diseases (4 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (631 citations), Biotechnology (75 citations), Cancer Research (112 citations) and Pulmonary and Respiratory Medicine (221 citations). Julius Strauss has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include James L. Gulley, Jeffrey Schlom, Renee N. Donahue, Ravi A. Madan, Jennifer L. Marté, Christopher R. Heery, Claudia Palena, Caroline Jochéms, Lisa M. Cordes and Marijo Bilušić. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Annals of Oncology, The Oncologist and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.